Michelle Harvie

Michelle Harvie

Manchester University

H-index: 40

North America-United States

About Michelle Harvie

Michelle Harvie, With an exceptional h-index of 40 and a recent h-index of 30 (since 2020), a distinguished researcher at Manchester University, specializes in the field of Diet and the prevention and management of cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Do people with type 2 diabetes find continuous and intermittent low-energy diets for weight loss and diabetes remission acceptable?

Emotion constructs and outcome measures following false positive breast screening test results: A systematic review of reporting clarity and selection rationale

Healthcare professionals' experiences of caring for women with false‐positive screening test results in the National Health Service Breast Screening Programme

Weight, weight gain and behavioural risk factors in women attending a breast cancer family history, risk and prevention clinic: an observational study

Body composition changes during breast cancer preventive treatment with anastrozole: Findings from the IBIS-II trial

Manchester Intermittent Diet in Gestational Diabetes Acceptability Study (MIDDAS-GDM): a two-arm randomised feasibility protocol trial of an intermittent low-energy diet (ILED …

Effectiveness of lifestyle interventions/culturally bespoke programmes in South Asian ethnic groups targeting weight loss for prevention and/or remission of type 2 diabetes: a …

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

Michelle Harvie Information

University

Position

___

Citations(all)

9602

Citations(since 2020)

5494

Cited By

5881

hIndex(all)

40

hIndex(since 2020)

30

i10Index(all)

73

i10Index(since 2020)

58

Email

University Profile Page

Google Scholar

Michelle Harvie Skills & Research Interests

Diet and the prevention and management of cancer

Top articles of Michelle Harvie

Do people with type 2 diabetes find continuous and intermittent low-energy diets for weight loss and diabetes remission acceptable?

Journal of Human Nutrition and Dietetics

2024/4/11

Joanna Brooks
Joanna Brooks

H-Index: 12

Michelle Harvie
Michelle Harvie

H-Index: 26

Emotion constructs and outcome measures following false positive breast screening test results: A systematic review of reporting clarity and selection rationale

2024/4

Michelle Harvie
Michelle Harvie

H-Index: 26

Healthcare professionals' experiences of caring for women with false‐positive screening test results in the National Health Service Breast Screening Programme

Health Expectations

2024/4

Weight, weight gain and behavioural risk factors in women attending a breast cancer family history, risk and prevention clinic: an observational study

BJC Reports

2024/3/14

Emma Barrett
Emma Barrett

H-Index: 6

Michelle Harvie
Michelle Harvie

H-Index: 26

Body composition changes during breast cancer preventive treatment with anastrozole: Findings from the IBIS-II trial

Preventive Medicine Reports

2024/2/1

Manchester Intermittent Diet in Gestational Diabetes Acceptability Study (MIDDAS-GDM): a two-arm randomised feasibility protocol trial of an intermittent low-energy diet (ILED …

BMJ open

2024/2/1

Effectiveness of lifestyle interventions/culturally bespoke programmes in South Asian ethnic groups targeting weight loss for prevention and/or remission of type 2 diabetes: a …

2024/1/18

Manchester Intermittent and Daily diet Type 1 Diabetes App Study (MIDDAS-Type 1): Protocol for a randomised feasibility trial of an intermittent and continuous low-energy diet …

BMJ open

2023/7/1

Michelle Harvie
Michelle Harvie

H-Index: 26

Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised …

British journal of cancer

2023/6/15

BE-WEL Trial (Breast: Evaluation of Weight and Exercise for Lymphoedema) Testing weight control and exercise programmes for women with breast cancer related lymphoedema: a …

2023/12/13

Michelle Harvie
Michelle Harvie

H-Index: 26

Emma Barrett
Emma Barrett

H-Index: 6

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

The Lancet Regional Health–Europe

2023/6/1

Randomised controlled trial of breast cancer and multiple disease prevention weight loss programmes vs written advice amongst women attending a breast cancer family history clinic

British Journal of Cancer

2023/5/18

Estimating the Cost of 3 Risk Prediction Strategies for Potential Use in the United Kingdom National Breast Screening Program

MDM Policy & Practice

2023/5

Michelle Harvie
Michelle Harvie

H-Index: 26

David French
David French

H-Index: 41

Long COVID research: an update from the PHOSP-COVID Scientific Summit

The Lancet Respiratory Medicine

2023/11/1

Obesity at age 20 and weight gain during adulthood increase risk of total and premature all-cause mortality: findings from women attending breast screening in Manchester

BMC Women's Health

2023/1/13

Reversing the genomic, epigenetic, and triple-negative breast cancer–enhancing effects of obesity

Cancer Prevention Research

2022/9/1

Weida Gong
Weida Gong

H-Index: 6

Michelle Harvie
Michelle Harvie

H-Index: 26

See List of Professors in Michelle Harvie University(Manchester University)